China Resources Double-Crane (600062.SH) subsidiary receives drug registration certificate for Compound Potassium Hydrogen Phosphate Injection

Zhitong Finance APP News, China Resources Double-Crane (600062.SH) announced that recently, its wholly-owned subsidiary Anhui Double-Crane Pharmaceutical Co., Ltd. received the "Drug Registration Certificate" for Compound Potassium Phosphate Hydrogen Injection issued by the National Medical Products Administration. Compound Potassium Phosphate Hydrogen Injection serves as a phosphorus supplement: 1. When oral or enteral nutrition is impossible, insufficient, or contraindicated, it is used to correct hypophosphatemia in adult and pediatric patients. 2. When oral or enteral nutrition is impossible, insufficient, or contraindicated, it is used for parenteral nutrition in adult and pediatric patients.